Clinical Effects of Hypertension on the Mortality of Patients with Acute Myocardial Infarction

The incidence of ischemic heart disease has been increased rapidly in Korea. However, the clinical effects of antecedent hypertension on acute myocardial infarction have not been identified. We assessed the relationship between antecedent hypertension and clinical outcomes in 7,784 patients with acute myocardial infarction in the Korea Acute Myocardial Infarction Registry during one-year follow-up. Diabetes mellitus, hyperlipidemia, cerebrovascular disease, heart failure, and peripheral artery disease were more prevalent in hypertensives (n=3,775) than nonhypertensives (n=4,009). During hospitalization, hypertensive patients suffered from acute renal failure, shock, and cerebrovascular event more frequently than in nonhypertensives. During follow-up of one-year, the incidence of major adverse cardiac events was higher in hypertensives. In multi-variate adjustment, old age, Killip class ≥III, left ventricular ejection fraction <45%, systolic blood pressure <90 mmHg on admission, post procedural TIMI flow grade ≤2, female sex, and history of hypertension were independent predictors for in-hospital mortality. However antecedent hypertension was not significantly associated with one-year mortality. Hypertension at the time of acute myocardial infarction is associated with an increased rate of in-hospital mortality.

[1]  V. Roger,et al.  The incidence of stroke after myocardial infarction: a meta-analysis. , 2006, The American journal of medicine.

[2]  H. Kasanuki,et al.  Clinical characteristics and early outcomes of very elderly patients in the reperfusion era. , 2004, International journal of cardiology.

[3]  R. Devereux,et al.  Inter-relationships between hypertension, left ventricular hypertrophy and coronary heart disease. , 1993, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[4]  R. Collins,et al.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002, The Lancet.

[5]  G. Khor,et al.  Cardiovascular epidemiology in the Asia-Pacific region. , 2001, Asia Pacific journal of clinical nutrition.

[6]  A. Dyer,et al.  Relationship of blood pressure to 25-year mortality due to coronary heart disease, cardiovascular diseases, and all causes in young adult men: the Chicago Heart Association Detection Project in Industry. , 2001, Archives of internal medicine.

[7]  M. Jeong,et al.  Clinical safety of drug-eluting stents in the Korea acute myocardial infarction registry. , 2008, Circulation Journal.

[8]  J. Cho,et al.  Gender differences of success rate of percutaneous coronary intervention and short term cardiac events in Korea Acute Myocardial Infarction Registry. , 2008, International journal of cardiology.

[9]  K. Eagle,et al.  Comparison of patients with acute coronary syndrome with and without systemic hypertension. , 2003, The American journal of cardiology.

[10]  A. Maggioni,et al.  A simple electrocardiographic predictor of the outcome of patients with acute myocardial infarction treated with a thrombolytic agent. A Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2)-Derived Analysis. , 1994, Journal of the American College of Cardiology.

[11]  S. Yusuf,et al.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.

[12]  M. Pfeffer,et al.  Predictors of late development of heart failure in stable survivors of myocardial infarction: the CARE study. , 2003, Journal of the American College of Cardiology.

[13]  E. Tuzcu,et al.  Effects of normal, pre-hypertensive, and hypertensive blood pressure levels on progression of coronary atherosclerosis. , 2006, Journal of the American College of Cardiology.

[14]  Simon Capewell,et al.  Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. , 2007, The New England journal of medicine.

[15]  S. Solomon,et al.  Effect of Antecedent Hypertension and Follow-Up Blood Pressure on Outcomes After High-Risk Myocardial Infarction , 2008, Hypertension.

[16]  M. Jeong,et al.  The Impact of Initial Treatment Delay Using Primary Angioplasty on Mortality among Patients with Acute Myocardial Infarction: from the Korea Acute Myocardial Infarction Registry , 2008, Journal of Korean medical science.

[17]  G. Lamas,et al.  Antecedent hypertension and the effect of captopril on the risk of adverse cardiovascular outcomes after acute myocardial infarction with left ventricular systolic dysfunction: Insights from the Survival and Ventricular Enlargement Trial. , 2004, American heart journal.

[18]  T. Ogihara,et al.  Links between hypertension and myocardial infarction. , 1996, American heart journal.

[19]  J. Boura,et al.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction : a quantitative review of 23 randomised trials , 2022 .

[20]  S. Lewington Prospective studies collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies (vol 360, pg 1903, 2002) , 2003 .

[21]  M. Pfeffer,et al.  Mortality and Morbidity Remain High Despite Captopril and/or Valsartan Therapy in Elderly Patients With Left Ventricular Systolic Dysfunction, Heart Failure, or Both After Acute Myocardial Infarction: Results From the Valsartan in Acute Myocardial Infarction Trial (VALIANT) , 2005, Circulation.

[22]  A. Dobson,et al.  Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations , 2000, The Lancet.

[23]  Miyong T. Kim,et al.  Assessing risk factors of coronary heart disease and its risk prediction among Korean adults: the 2001 Korea National Health and Nutrition Examination Survey. , 2006, International journal of cardiology.

[24]  R. Califf,et al.  Recent trends in the care of patients with non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE initiative. , 2006, Archives of internal medicine.

[25]  C. Frampton,et al.  Antecedent hypertension and heart failure after myocardial infarction. , 2002, Journal of the American College of Cardiology.

[26]  S. Willich,et al.  Cardiac risk factors, medication, and recurrent clinical events after acute coronary disease; a prospective cohort study. , 2001, European heart journal.

[27]  Roberto Pastor-Barriuso,et al.  Systolic Blood Pressure, Diastolic Blood Pressure, and Pulse Pressure: An Evaluation of Their Joint Effect on Mortality , 2003, Annals of Internal Medicine.

[28]  J. Herlitz,et al.  Five-year prognosis after acute myocardial infarction in relation to a history of hypertension. , 1996, American journal of hypertension.

[29]  B. J. Gersh Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980–2000 , 2008 .

[30]  Á. Avezum,et al.  Risk factors for myocardial infarction in Brazil. , 2003, American heart journal.